- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
CDC & NCI Release US Cancer Incidence Report
The stats show that Non-Hodgkin Lymphoma (NHL) is the fifth most common cancer to strike adults males, with an incidence rate of 23.0 per 100,000.
The incidence of NHL among adult women is lower, 16.2 per 100,000, but it still rates as the fifth most common cancer to strike women.
Collectively for men and women in the US of all ages and races, NHL’s mortality rate of 7.6 per 100,000 ranks eighth, just behind Leukemias (7.4). Compare this to the mortality rate for lung cancers (54.1), the highest in the report.
Among male and female children age 19 and younger, Leukemias have the highest rate of occurrence (4.2 per 100,000), with Acute Lymphocytic Leukemia being the dominant form. Hodgkin Lymphoma (1.2 per 100,000) has the third highest rate of occurrence, and NHL (1.1), the fourth.
The full report can be seen by clicking here.